Targeting thymidine phosphorylase alleviates resistance to dendritic cell immunotherapy in colorectal cancer and promotes antitumor immunity

Overview of attention for article published in Frontiers in immunology, August 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 5 X users, with an upper bound of 34,511 followers.

RT @DenCell_Papers: Targeting thymidine phosphorylase alleviates resistance to dendritic cell immunotherapy in colorectal cancer and promot…

15 Sep 2022

Reply Repost Favourite

RT @DCell_papers: Targeting thymidine phosphorylase alleviates resistance to dendritic cell immunotherapy in colorectal cancer and promotes…

15 Sep 2022

Reply Repost Favourite

Targeting thymidine phosphorylase alleviates resistance to dendritic cell immunotherapy in colorectal cancer and promotes antitumor immunity https://t.co/uHX7qj3Vtu

14 Sep 2022

Reply Repost Favourite

Targeting thymidine phosphorylase alleviates resistance to dendritic cell immunotherapy in colorectal cancer and promotes antitumor immunity https://t.co/tCb8E0ZhxM

13 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.